|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/20/22 Global Arena Holding, Inc. 10-Q/A 6/30/22 58:6.3M BioRegenx Inc. |
Document/Exhibit Description Pages Size
1: 10-Q/A Gahc 10Q2Q22 Am1 HTML 1.27M
2: EX-31 Certification -- §302 - SOA'02 -- HTML 20K
gahc10q2q22am1exhibit31
3: EX-32 Certification -- §906 - SOA'02 -- HTML 17K
gahc10q2q22am1exhibit32
9: R1 Document and Entity Information HTML 69K
10: R2 Condensed Consolidated Balance Sheets HTML 100K
11: R3 Condensed Consolidated Balance Sheets HTML 39K
(Parenthetical)
12: R4 Condensed Consolidated Statements of Operations HTML 112K
(Unaudited)
13: R5 Condensed Consolidated Statements of Stockholders' HTML 81K
Deficit
14: R6 Condensed Consolidated Statements of Cash Flows HTML 87K
(Unaudited)
15: R7 Organization HTML 34K
16: R8 Summary of Significant Accounting Policies HTML 107K
17: R9 Acquisition Deposits HTML 25K
18: R10 Accrued Expenses HTML 32K
19: R11 Promissory Notes Payable HTML 21K
20: R12 Convertible Promissory Notes Payable HTML 54K
21: R13 Derivative Financial Instruments HTML 43K
22: R14 Stockholders' Deficit HTML 119K
23: R15 Commitments and Contingencies HTML 24K
24: R16 Agreements HTML 46K
25: R17 Subsequent Events HTML 28K
26: R18 Summary of Significant Accounting Policies HTML 137K
(Policies)
27: R19 Summary of Significant Accounting Policies HTML 79K
(Tables)
28: R20 Accrued Expenses (Tables) HTML 31K
29: R21 Convertible Promissory Notes Payable (Tables) HTML 50K
30: R22 Derivative Financial Instruments (Tables) HTML 44K
31: R23 Stockholders' Deficit (Tables) HTML 111K
32: R24 Organization (Narratives) (Details) HTML 95K
33: R25 Summary of Significant Accounting Policies HTML 28K
(Schedule Of Antidilutive Securities Excluded From
Earnings) (Details)
34: R26 Summary of Significant Accounting Policies HTML 32K
(Schedule Of Fair Value Of Assets And Liabilities)
(Details)
35: R27 Acquisition Deposits (Narratives) (Details) HTML 82K
36: R28 Accrued Expenses (Schedule of Accrued Liabilities) HTML 26K
(Details)
37: R29 Promissory Notes Payable (Narratives) (Details) HTML 41K
38: R30 Convertible Promissory Notes Payable (Schedule Of HTML 39K
Convertible Promissory Notes Payable) (Details)
39: R31 Convertible Promissory Notes Payable (Schedule Of HTML 50K
Convertible Promissory Notes Payable) (Details)
(Parenthetical)
40: R32 Convertible Promissory Notes Payable (Schedule Of HTML 35K
Rollfoward Of Convertible Promissory Notes
Payable) (Details)
41: R33 Convertible Promissory Notes Payable (Narrative) HTML 20K
(Details)
42: R34 Derivative Financial Instruments (Schedule Of HTML 34K
Valuation Techniques Used In Fair Value Of
Derivative Liability) (Details)
43: R35 Derivative Financial Instruments (Schedule Of HTML 27K
Changes In Fair Value Of Financial Derivatives)
(Details)
44: R36 Stockholders' Deficit (Schedule Of Stock Option HTML 51K
Activity) (Details)
45: R37 Stockholders' Deficit (Schedule Of Exercise Price HTML 26K
For Options Outstanding) (Details)
46: R38 Stockholders' Deficit (Schedule Of Warrant HTML 55K
Activity) (Details)
47: R39 Stockholders' Deficit (Schedule Of Exercise Price HTML 74K
For Warrants Outstanding) (Details)
48: R40 Stockholders' Deficit (Series B Preferred Stock) HTML 37K
(Narratives) (Details)
49: R41 Stockholders' Deficit (Common Stock) (Narratives) HTML 37K
(Details)
50: R42 Stockholders' Deficit (Warrant Activity) HTML 36K
(Narratives) (Details)
51: R43 Commitments and Contingencies (Narratives) HTML 31K
(Details)
52: R44 Agreements (Narratives) (Details) HTML 200K
53: R45 Subsequent Events (Narratives) (Details) HTML 48K
56: XML IDEA XML File -- Filing Summary XML 106K
54: XML XBRL Instance -- gahc-20220630_htm XML 1.45M
55: EXCEL IDEA Workbook of Financial Reports XLSX 119K
4: EX-101.CAL XBRL Calculations -- gahc-20220630_cal XML 88K
5: EX-101.DEF XBRL Taxonomy Extension Definitive Linkbase XML 536K
Document -- gahc-20220630_def
6: EX-101.LAB XBRL Labels -- gahc-20220630_lab XML 1.71M
7: EX-101.PRE XBRL Presentations -- gahc-20220630_pre XML 810K
8: EX-101.SCH XBRL Schema -- gahc-20220630 XSD 185K
57: JSON XBRL Instance as JSON Data -- MetaLinks 326± 487K
58: ZIP XBRL Zipped Folder -- 0001877104-22-000008-xbrl Zip 241K
| Converted by EDGARwiz |
302 CERTIFICATION
I, John Matthews, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Global Arena Holding, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report, our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.
Date: September 20, 2022
Chief Executive Officer
Chief Financial Officer
| This ‘10-Q/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/20/22 | |||
| For Period end: | 6/30/22 | 10-Q, NT 10-Q | ||
| List all Filings | ||||